Posted on Feb 3, 2012 By Pharmaceutical Injury Attorney
The Food and Drug Administration's advisory committee is saying that the attention deficit disorder drug Focalin should include on its label the risk of suicidal thoughts. Focalin is approved for ...
Continue reading "ADHD Drug Should Come With Suicide Risk Warning, Experts Say" »